Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-173623
Filing Date
2025-08-05
Accepted
2025-08-05 17:14:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d23741d424b5.htm 424B5 180190
2 GRAPHIC g23741g72h99.jpg GRAPHIC 43981
  Complete submission text file 0001193125-25-173623.txt   233350
Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

EIN.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-288971 | Film No.: 251186171
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)